Huons Co

Huons Co Equity

The The Equity of Huons Co (243070.KQ) as of Oct 19, 2026 is 373.91 B KRW. In the previous year, The Equity was 345.97 B KRW — a change of 8.07% (higher).

Equity

373.91 BKRW

YoY

8.07%

Last updated:

In 2025, Huons Co's equity was 373.91 B KRW, a 8.07% increase from the 345.97 B KRW equity in the previous year.

The Huons Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
163.27 B KRW
Jan 1, 2019
194.52 B KRW
Jan 1, 2020
238.80 B KRW
Jan 1, 2021
266.09 B KRW
Jan 1, 2022
282.46 B KRW
Jan 1, 2023
325.40 B KRW
Jan 1, 2024
345.97 B KRW
Jan 1, 2025
373.91 B KRW
The Huons Co Equity history
YEAREquityYoY
373.91 BKRW+8.07%
345.97 BKRW+6.32%
325.40 BKRW+15.21%
282.46 BKRW+6.15%
266.09 BKRW+11.43%
238.80 BKRW+22.77%
194.52 BKRW+19.14%
163.27 BKRW+33.07%
122.69 BKRW+30.69%
93.88 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Huons Co Stock analysis

What does Huons Co do? Huons Co., Ltd. is a pharmaceutical manufacturer and seller headquartered in Seongnam, South Korea. The company engages in the production and distribution of pharmaceutical products within the Health Care sector. Huons Co., Ltd. went public on 3 June 2016, marking its entry into the stock market. The firm operates primarily in the pharmaceutical industry, focusing on bringing healthcare solutions to market from its base in Gyeonggi-Do. Huons Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Huons Co's Equity

Huons Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Huons Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Huons Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Huons Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Huons Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Huons Co stock

The Equity of Huons Co is 373.91 B KRW in 2025.

The Equity of Huons Co changed from 345.97 B KRW to 373.91 B KRW, representing a 8.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Huons Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Huons Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Huons Co

All Key Metrics — Huons Co